Corrigendum to -Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db-db MiceReportar como inadecuado




Corrigendum to -Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db-db Mice - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Mediators of Inflammation - Volume 2016 2016, Article ID 3151986, 2 pages -

Corrigendum

Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China

Department of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China

Department of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China

Received 8 June 2016; Accepted 15 August 2016

Copyright © 2016 Xiao-Wen Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled -Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db-db Mice- 1, in Figure 3cA, the value of ordinate should be narrowed down to 0.01 times that of the data presented. And in Figure 6b, the abscissa p-65-p65 should be changed to p-p65-p65. The two corrected figures are presented here.

Figure 3: Irb alleviated diabetes-induced podocyte injury and the thickening of the GBM. a Representative fields of podocyte foot processes under TEM scale bars: 2 μm; red arrow indicates podocyte foot process effacement. b Representative fields of nephrin, as labeled by immunohistochemical staining scale bars: 50 μm. c Quantification of the GBM thickness A and immunohistochemical staining B. The bars in panel c show the mean expression in arbitrary units error bars, SD. compared with db-m; compared with db-db -test.Figure 6: Irb inhibited NF-κB pathway activation in db-db mice. a Representative immunoblot of p-IκBα, IκBα, p-p65, and p65 in the kidney. b Quantification of the immunoblot: the ratio between p-IκBα and IκBα and the ratio between p-p65 and p65 are presented. The bars in panel b show the mean expression in arbitrary units error bars, SD. compared with db-m; compared with db-db -test.References

X.-W. Chen, X.-Y. Du, Y.-X. Wang et al. -Irbesartan ameliorates diabetic nephropathy by suppressing the RANKL-RANK-NF-κB pathway in type 2 diabetic db-db mice,- Mediators of Inflammation, vol. 2016, Article ID 1405924, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus



Autor: Xiao-Wen Chen, Xiao-Yan Du, Yu-Xian Wang, Jian-Cheng Wang, Wen-Ting Liu, Wen-Jing Chen, Hong-Yu Li, Fen-Fen Peng, Zhao-Zho

Fuente: https://www.hindawi.com/



DESCARGAR PDF




Documentos relacionados